| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
3,378 |
3,302 |
$51K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
1,628 |
1,619 |
$47K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
3,596 |
2,966 |
$40K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
2,572 |
2,542 |
$33K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
2,631 |
1,848 |
$32K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,513 |
2,472 |
$31K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,528 |
1,513 |
$24K |
| 97802 |
|
3,388 |
2,186 |
$17K |
| 99442 |
|
3,796 |
3,587 |
$17K |
| H0049 |
Alcohol and/or drug screening |
2,135 |
2,109 |
$8K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,925 |
2,309 |
$4K |
| 3079F |
|
2,261 |
2,226 |
$4K |
| 3074F |
|
2,717 |
2,676 |
$4K |
| 99401 |
|
767 |
757 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
424 |
413 |
$3K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
5,179 |
3,661 |
$3K |
| 1126F |
|
4,039 |
3,191 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
2,528 |
2,522 |
$2K |
| S9470 |
Nutritional counseling, dietitian visit |
3,214 |
2,756 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
130 |
125 |
$2K |
| 82962 |
|
2,944 |
2,688 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,100 |
1,042 |
$1K |
| 82274 |
|
238 |
222 |
$1K |
| 96127 |
|
2,671 |
2,636 |
$1K |
| 36410 |
|
286 |
284 |
$1K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$834.88 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
1,306 |
1,303 |
$720.00 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
1,323 |
915 |
$664.24 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
24 |
24 |
$635.22 |
| 96160 |
|
1,543 |
1,526 |
$625.96 |
| G9665 |
Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy |
259 |
196 |
$564.85 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$500.39 |
| 99385 |
|
12 |
12 |
$448.07 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
1,149 |
746 |
$425.10 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12 |
12 |
$408.50 |
| 3048F |
|
813 |
705 |
$360.00 |
| 3050F |
|
734 |
629 |
$328.00 |
| 0521F |
|
1,567 |
1,517 |
$320.00 |
| 3061F |
|
828 |
739 |
$304.00 |
| 1125F |
|
657 |
639 |
$300.00 |
| 82270 |
|
373 |
347 |
$276.30 |
| 82272 |
|
346 |
320 |
$264.74 |
| 99386 |
|
12 |
12 |
$248.48 |
| 81000 |
|
2,611 |
2,592 |
$247.75 |
| 99408 |
|
1,709 |
1,627 |
$237.46 |
| 3049F |
|
526 |
475 |
$144.00 |
| 3078F |
|
730 |
717 |
$130.00 |
| 82948 |
|
1,201 |
1,148 |
$114.84 |
| H0001 |
Alcohol and/or drug assessment |
3,056 |
2,396 |
$94.93 |
| 99497 |
|
13 |
12 |
$93.54 |
| 97803 |
|
14 |
14 |
$88.02 |
| 86480 |
|
62 |
62 |
$75.00 |
| 3044F |
|
136 |
104 |
$56.00 |
| 0513F |
|
366 |
364 |
$40.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
3,211 |
2,491 |
$37.50 |
| 81003 |
|
2,012 |
2,008 |
$9.51 |
| 1157F |
|
25 |
25 |
$8.00 |
| 1158F |
|
517 |
513 |
$8.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,150 |
2,139 |
$7.28 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
2,896 |
2,232 |
$4.73 |
| 82947 |
|
250 |
250 |
$1.65 |
| H0003 |
Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs |
855 |
847 |
$1.64 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
240 |
240 |
$1.56 |
| 86703 |
|
1,635 |
1,633 |
$1.48 |
| 84442 |
|
2,065 |
2,060 |
$1.08 |
| 84479 |
|
1,807 |
1,801 |
$1.01 |
| 82043 |
|
2,406 |
2,400 |
$0.83 |
| 83719 |
|
1,974 |
1,968 |
$0.81 |
| 86592 |
|
1,761 |
1,740 |
$0.67 |
| 4010F |
|
2,328 |
1,545 |
$0.63 |
| 3008F |
|
3,930 |
3,851 |
$0.62 |
| 4210F |
|
2,307 |
1,527 |
$0.52 |
| 3066F |
|
1,065 |
770 |
$0.43 |
| 2022F |
|
975 |
671 |
$0.34 |
| 80053 |
Comprehensive metabolic panel |
2,276 |
2,272 |
$0.22 |
| 82040 |
|
1,988 |
1,982 |
$0.17 |
| 80061 |
Lipid panel |
2,057 |
2,052 |
$0.12 |
| 84520 |
|
1,930 |
1,912 |
$0.11 |
| 82565 |
|
1,966 |
1,949 |
$0.09 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,801 |
1,798 |
$0.07 |
| 86803 |
|
222 |
222 |
$0.07 |
| 86709 |
|
220 |
220 |
$0.07 |
| 87522 |
Neg quan hep c or qual rna |
224 |
224 |
$0.06 |
| 84152 |
|
28 |
28 |
$0.06 |
| 3045F |
|
144 |
114 |
$0.03 |
| 80051 |
|
2,269 |
2,264 |
$0.02 |
| 86705 |
|
223 |
223 |
$0.01 |
| 3014F |
|
2,226 |
1,501 |
$0.00 |
| 4144F |
|
174 |
127 |
$0.00 |
| 3754F |
|
1,959 |
1,953 |
$0.00 |
| 84132 |
|
484 |
481 |
$0.00 |
| G9912 |
Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy |
3,189 |
2,388 |
$0.00 |
| 1000F |
|
4,096 |
2,973 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
4,798 |
3,564 |
$0.00 |
| 4060F |
|
317 |
223 |
$0.00 |
| 84480 |
|
394 |
394 |
$0.00 |
| 3011F |
|
5,020 |
3,543 |
$0.00 |
| 1170F |
|
144 |
139 |
$0.00 |
| 1036F |
|
3,840 |
2,784 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
2,613 |
2,526 |
$0.00 |
| 82575 |
|
420 |
419 |
$0.00 |
| 2001F |
|
2,561 |
2,519 |
$0.00 |
| 3017F |
|
1,920 |
1,328 |
$0.00 |
| 86706 |
|
221 |
221 |
$0.00 |
| G9226 |
Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) |
1,717 |
1,685 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
191 |
188 |
$0.00 |
| G9667 |
Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy) |
269 |
188 |
$0.00 |
| 4140F |
|
155 |
110 |
$0.00 |
| G8725 |
Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol) |
60 |
60 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
119 |
117 |
$0.00 |
| 80069 |
|
406 |
405 |
$0.00 |
| 87110 |
|
74 |
74 |
$0.00 |
| 2016F |
|
37 |
37 |
$0.00 |
| 1005F |
|
24 |
24 |
$0.00 |
| 2015F |
|
24 |
24 |
$0.00 |
| 3016F |
|
2,961 |
2,241 |
$0.00 |
| 3725F |
|
3,383 |
2,639 |
$0.00 |
| 1159F |
|
739 |
716 |
$0.00 |
| G9383 |
Patient received screening for hcv infection within the 12 month reporting period |
1,324 |
1,318 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
367 |
362 |
$0.00 |
| 4064F |
|
339 |
248 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
335 |
230 |
$0.00 |
| 1033F |
|
3,088 |
2,043 |
$0.00 |
| G8506 |
Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
728 |
553 |
$0.00 |
| 3085F |
|
819 |
809 |
$0.00 |
| 1090F |
|
1,871 |
1,850 |
$0.00 |
| 90399 |
|
217 |
217 |
$0.00 |
| 2028F |
|
2,074 |
2,040 |
$0.00 |
| G8404 |
Lower extremity neurological exam performed and documented |
103 |
83 |
$0.00 |
| 3015F |
|
1,393 |
943 |
$0.00 |
| 4062F |
|
238 |
174 |
$0.00 |
| 83721 |
|
347 |
347 |
$0.00 |
| 2014F |
|
812 |
802 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
2,586 |
2,501 |
$0.00 |
| 1160F |
|
739 |
716 |
$0.00 |
| 0403T |
|
180 |
180 |
$0.00 |
| 3288F |
|
25 |
25 |
$0.00 |
| 1494F |
|
12 |
12 |
$0.00 |
| 5250F |
|
24 |
24 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$0.00 |
| 3046F |
|
17 |
12 |
$0.00 |